This inventor holds 3 USPTO granted patents. Top assignee: Toray Industries, Inc.. Active years: 1987-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kusatsu, JP (1987 - 1988)
- Shiga, JP (1992)
Company Filing History:
Years Active: 1987-1992
Title: Masashi Kodama: Innovator in Medical Technology
Introduction
Masashi Kodama is a notable inventor based in Kusatsu, Japan. He has made significant contributions to the field of medical technology, particularly in the treatment of malignant tumors and endotoxemia. With a total of 3 patents, his work has the potential to impact patient care and treatment methodologies.
Latest Patents
Kodama's latest patents include a method for treating malignant tumors using lipopolysaccharides derived from the cell walls of Gram-negative bacteria. This innovative approach involves immobilizing these substances on a solid carrier and passing the blood, blood plasma, or blood serum of a tumor-bearing patient over this material to treat the tumor effectively. Another significant patent focuses on endotoxin detoxifying materials, which comprise a fibrous carrier to which Polymyxin is fixed. This invention allows for the direct and safe contact of blood with Polymyxin, providing a new method for therapy against endotoxemia or its prophylaxis.
Career Highlights
Kodama is associated with Toray Industries, Inc., a leading company in advanced materials and technology. His work at Toray has allowed him to explore innovative solutions in medical treatments, contributing to the advancement of healthcare technologies.
Collaborations
Throughout his career, Kodama has collaborated with esteemed colleagues such as Kazuo Teramoto and Toru Tani. These partnerships have fostered a collaborative environment that encourages innovation and the development of groundbreaking medical technologies.
Conclusion
Masashi Kodama's contributions to medical technology through his patents and collaborations highlight his role as a significant inventor in the field. His innovative approaches to treating malignant tumors and endotoxemia demonstrate the potential for advancements in patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
